Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation
Fang-Tong Liu, Chao-Ling Wan, Yuan-Hong Huang, Han-Yu Cao, Xiao-Yu Lyu, Zi-Hao Wang et al. Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation. // Annals of Hematology. – 2024. – DOI: 10.1007/s00277-024-06137-5. – URL: https://doi.org/10.1007/s00277-024-06137-5
Fang-Tong Liu, Chao-Ling Wan, Yuan-Hong Huang, Han-Yu Cao, Xiao-Yu Lyu, Zi-Hao Wang, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Yang Zhang, & Sheng-Li Xue (2024). Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation. Annals of Hematology. https://doi.org/10.1007/s00277-024-06137-5
Fang-Tong Liu, et al. “Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation.” Annals of Hematology, 2024. doi:10.1007/s00277-024-06137-5.
@article{Liu2024,
title = {Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation},
author = {Liu, Fang-Tong and Wan, Chao-Ling and Huang, Yuan-Hong and Cao, Han-Yu and Lyu, Xiao-Yu and Wang, Zi-Hao and Huang, Si-Man and Tan, Kai-Wen and Ge, Shuai-Shuai and Zhang, Yang and Xue, Sheng-Li},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-06137-5},
url = {https://doi.org/10.1007/s00277-024-06137-5}
}